Company:  ALIMERA SCIENCES INC (ALIM)
Form Type:  8-K
Filing Date:  8/28/2012 
CIK:  0001267602 
Address:  6120 WINDWARD PARKWAY
STE 290
 
City, State, Zip:  ALPHARETTA, Georgia 30005 
Telephone:  (678) 990-5740 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.14  
Change: 
0.03 (0.49%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$247.45M
Description of Business
Alimera Sciences, Inc., and its subsidiaries (we, Alimera or the Company), is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. We are presently focused on diseases affecting the back of the eye, or retina, because we believe these diseases are not well treated with current therapies and represent a significant market opportunity. Our only commercial product is ILUVIEN�, which has received marketing authorization in Austria, the United Kingdom, Portugal, France, Germany and Spain, and has been recommended for marketing authorization in Italy, for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 4 MATTERS RELATED TO ACCOUNTANTS
      Item 4.01 Changes in Registrant's Certifying Accountant
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 16.1
BROKERAGE PARTNERS